Abstract
Cellebrite will release its quarterly results on November 12, 2026 Pre-MKt; consensus anticipates revenue of 145.92 million US dollars year over year up 19.60% and adjusted EPS of 0.16 year over year up 26.11%, with investors watching delivery versus the 145–148 million US dollars guidance and margin cadence.Market Forecast
The market currently expects Cellebrite to post revenue of 145.92 million US dollars this quarter, implying 19.60% year-over-year growth, with adjusted EPS of 0.16, up 26.11% year over year; the company’s own guidance from the prior update called for 145–148 million US dollars of revenue and full-year revenue of 555–561 million US dollars. Forecast EBIT stands at 41.34 million US dollars, a year-over-year increase of 37.38%. No explicit gross margin or net profit guidance was provided.Subscriptions remain the central commercial driver, with last quarter’s gross margin at 80.78% and management pointing to a continuation of high-margin software and services mix that underpins operating leverage. The most promising area is the recurring subscription base, evidenced by subscription ARR of 480.80 million US dollars in 2025, up 21.00% year over year; within the latest quarter, subscriptions contributed roughly three-quarters of sales by mix.
Last Quarter Review
Cellebrite’s previous quarter delivered revenue of 131.14 million US dollars, up 15.77% year over year, a gross margin of 80.78%, GAAP net profit attributable to shareholders of 6.37 million US dollars for a 4.86% net profit margin, and adjusted EPS of 0.11, down 8.33% year over year. EBIT reached 29.81 million US dollars, up 13.66% year over year, supported by disciplined operating expenses and a high software mix.On the commercial front, subscriptions dominated the sales mix at roughly 74.87%, while management reiterated a 145–148 million US dollars revenue outlook for the current quarter and progressed the broader recurring-revenue strategy. As a structural indicator of momentum, subscription ARR for 2025 was 480.80 million US dollars, up 21.00% year over year, highlighting durable demand for recurring contracts.
Current Quarter Outlook
Subscriptions and recurring monetization
Expectations for the quarter center on revenue of 145.92 million US dollars, implying 19.60% year-over-year growth, and adjusted EPS of 0.16, up 26.11%. The mix remains tilted toward subscriptions, a profile that historically correlates with higher gross margins and growing operating leverage as deployments scale and renewal cohorts expand. Given last quarter’s gross margin of 80.78%, investors are looking for stability in gross profitability as the company leans into software, cloud-delivered capabilities, and services with limited incremental cost at scale.The near-term earnings bridge rests on execution against renewals and upsells in government and enterprise accounts, coupled with prudent expense control. Forecast EBIT of 41.34 million US dollars suggests further operating margin expansion year over year, a view consistent with the company’s model when subscription revenue scales faster than headcount and delivery costs. Any commentary on retention rates, average deal size, or pricing on multiyear renewals could become a key read-through for sustainability of this earnings cadence in the fourth quarter and into 2027.
Participants will also parse management’s remarks on deferred revenue and billings to triangulate forward growth embedded in contracts. A pattern of stronger billings and contracted backlog typically foreshadows resilient top-line performance, while any shift in invoicing timing or elongated procurement cycles may affect quarterly phasing without necessarily altering the annual trajectory. Clarity on these items will be central for investors translating subscription momentum into near-term revenue recognition.
Genesis expansion and enterprise initiatives
The company has broadened availability of its Genesis investigation platform to enterprise customers and expanded coverage to additional international markets, including Australia and the United Kingdom, with European Union availability guided shortly after. This roll-out is designed to extend use cases to areas such as employee investigations, financial fraud, insider threats, incident response, due diligence, and regulatory inquiries. While early contributions may be modest at the revenue line, the initiative can add incremental ARR and diversify the customer footprint.For the current quarter, investors will look for indications of early adoption, pilot-to-production conversion, and attach rates to existing product suites. Wins or pipeline updates in enterprise channels may serve as forward indicators for incremental growth in 2027 beyond the public-sector cadence. If management quantifies deal sizes, cycle times, or conversion ratios, the market can better assess the pace at which Genesis transitions from product availability to recurring revenue impact.
The trajectory of this expansion also matters for the margin narrative. Enterprise deployments that leverage cloud delivery and data analytics typically come with favorable gross margin characteristics. If execution remains disciplined, the contribution of enterprise subscriptions can support both revenue growth and EBIT expansion beyond what is embedded in the current-quarter consensus.
Stock price drivers this quarter
Three items are likely to shape the stock’s reaction: delivery versus the 145–148 million US dollars revenue outlook, full-year guideposts with any update to the 555–561 million US dollars range, and margin cadence relative to the 41.34 million US dollars EBIT forecast. A clean in-line result may not suffice given the stock’s sensitivity to guidance and the prior quarter’s volatility; investors will focus on the tone of management’s commentary on bookings, renewals, and the health of the demand pipeline. Evidence that the current-quarter strength is not a one-off, such as reaffirmed or raised full-year targets and solid billings trends, would be a constructive signal for the shares.Leadership changes are also on the radar. The appointment of Shiven Ramji as chief executive officer was announced alongside the last update. Investors will watch for early readouts on operating priorities, go-to-market execution, and resource allocation aimed at reinforcing recurring revenue growth while preserving cost discipline. Any articulation of product roadmap milestones or commercialization frameworks around cloud and analytics offerings can serve as a qualitative reinforcement for the numeric guide.
Corporate structure and capital markets items merit attention as well. The company has communicated plans to establish a new US parent corporation, with completion expected in the first half of 2027, which could have implications for index eligibility and investor access over time. Short-term trading dynamics may also reflect the market’s response to earlier guidance that trailed some external estimates and notable insider selling episodes reported during the summer and fall; the path to re-rating hinges on consistent delivery against guidance, clarity on full-year momentum, and credible commentary on bookings quality.
Analyst Opinions
Across the last six months, views that include explicit ratings skew bullish. Notably, J.P. Morgan assigned a Buy rating with a 16.00 US dollars price target, TD Cowen reiterated Buy with a 23.00 US dollars target, and Deutsche Bank maintained Buy while adjusting its target to 14.00 US dollars. The majority stance emphasizes confidence in recurring revenue durability and the margin framework implied by the quarter’s 19.60% revenue growth expectation, 26.11% forecast EPS growth, and 37.38% forecast EBIT growth.The constructive camp underscores several points. First, the guidance range of 145–148 million US dollars for the quarter brackets the 145.92 million US dollars consensus, leaving room for an in-line or modest beat if renewals and upsells close as planned. Second, last quarter’s 80.78% gross margin and 29.81 million US dollars EBIT (up 13.66% year over year) demonstrate a cost structure capable of supporting incremental profitability as higher-margin software and services scale. Third, the broadening availability of the Genesis platform to enterprises, together with ongoing product enhancements, provides additional levers to support ARR growth without proportionate cost increases.
Analysts are also attentive to what could close the gap between near-term volatility and the longer-term trajectory. They point to visibility from multi-year contracts and a growing base of recurring subscriptions as stabilizers, so long as customer retention and expansion metrics remain firm. In their view, confirmation that the full-year revenue range of 555–561 million US dollars remains intact, alongside an update that frames fourth-quarter phasing and early 2027 demand, would help the market look past short-term fluctuations in quarterly estimates. Overall, the bullish consensus anticipates that consistent execution against subscription-driven growth and disciplined expense management can support both revenue and earnings outperformance relative to the quarter’s benchmarks.
Comments